Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma

Yalcin, S; Lacin, S

Yalcin, S (reprint author), Hacettepe Univ, Inst Canc, Dept Med Oncol, Fac Med, TR-006100 Ankara, Turkey.

CANCER MANAGEMENT AND RESEARCH, 2019; 11 (): 7779

Abstract

Renal cell carcinoma (RCC) is the most common type of kidney malignancy, and the clear-cell subtype represents the majority of RCCs. RCC is a heteroge......

Full Text Link